The p53 Negative Regulator MDM4 Is Amplified and Over-Expressed in Hepatoblastoma

被引：0
|
作者：
Roy, A. [1 ]
Patel, K. U. [1 ]
Hamilton, K. L. [1 ]
Lu, X. [1 ]
Finegold, M. J. [1 ]
Lopez-Terrada, D. H. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1762
引用
收藏
页码：423A / 423A
页数：1
相关论文
共 50 条
  • [21] The expression of MDM2, MDM4, p53 and p21 in myeloid neoplasms and the effect of MDM2/MDM4 dual inhibitor
    Eskandari, Mohammad
    Shi, Yang
    Liu, John
    Albanese, Joseph
    Goel, Swati
    Verma, Amit
    Wang, Yanhua
    LEUKEMIA & LYMPHOMA, 2021, 62 (01) : 167 - 175
  • [22] Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4
    Grier, JD
    Xiong, SB
    Elizondo-Fraire, AC
    Parant, JM
    Lozano, G
    MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (01) : 192 - 198
  • [23] Peptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent review
    Teveroni, Emanuela
    Luca, Rossella
    Pellegrino, Marsha
    Ciolli, Germana
    Pontecorvi, Alfredo
    Moretti, Fabiola
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2016, 26 (12) : 1417 - 1429
  • [24] Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4
    Marine, J-C
    Francoz, S.
    Maetens, M.
    Wahl, G.
    Toledo, F.
    Lozano, G.
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (06): : 927 - 934
  • [25] Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4
    J-C Marine
    S Francoz
    M Maetens
    G Wahl
    F Toledo
    G Lozano
    Cell Death & Differentiation, 2006, 13 : 927 - 934
  • [26] Impact Of p53 Impaired Function On Outcomes Of Multiple Myeloma Patients Carrying Deleted TP53 and/Or Amplified MDM4
    Terragna, Carolina
    Martello, Marina
    Borsi, Enrica
    Pantani, Lucia
    Zamagni, Elena
    Tacchetti, Paola
    Annamaria, Brioli
    Zannetti, Beatrice Anna
    Dico, Flores
    Testoni, Nicoletta
    Marzocchi, Giulia
    Mancuso, Katia
    Rocchi, Serena
    Martinelli, Giovanni
    Cavo, Michele
    BLOOD, 2013, 122 (21)
  • [27] Impact of p53 impaired function on outcomes of multiple myeloma patients carrying deleted TP53 and/or amplified MDM4
    Terragna, Carolina
    Martello, Marina
    Borsi, Enrica
    Pantani, Lucia
    Zamagni, Elena
    Tacchetti, Paola
    Brioli, Annamaria
    Zannetti, Beatrice Anna
    Dico, Flores
    Testoni, Nicoletta
    Marzocchi, Giulia
    Mancuso, Katia
    Rocchi, Serena
    Martinelli, Giovanni
    Cavo, Michele
    CANCER RESEARCH, 2014, 74 (19)
  • [28] MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond
    Marine, Jean-Christophe
    Jochemsen, Aart G.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2016, 6 (07):
  • [29] Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability
    Pant, Vinod
    Xiong, Shunbin
    Iwakuma, Tomoo
    Quintas-Cardama, Alfonso
    Lozano, Guillermina
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (29) : 11995 - 12000
  • [30] The p53 inhibitor Mdm4 cooperates with multiple genetic lesions in tumourigenesis
    Xiong, Shunbin
    Pant, Vinod
    Zhang, Yun
    Aryal, Neeraj K.
    You, M. James
    Kusewitt, Donna
    Lozano, Guillermina
    JOURNAL OF PATHOLOGY, 2017, 241 (04): : 501 - 510
12345